Intuitive Surgical, Inc. ISRG
NASDAQ · Healthcare · Medical - Instruments & Supplies
$399.05
Close on Fri, 20 Nov 2026 · market value $138B
What the price is betting on
Priced for a lot to go rightAt $399, the price assumes revenue grows about 22% a year for five years, from $11.6B to about $27.2B by FY2030. That is about twice what analysts expect for the next two years and about the same as the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 10% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than ISRG? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$186
Base
$237
Bull
$303
Today $399
- Bear $186. Cash flow grows 7% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $237. Cash flow grows 12% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $303. Cash flow grows 17% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$12.2B$11.9B, on the path
- FY2027$14.9B$13.4B, below the path
- FY2028$18.2B$15B, below the path
- FY2029$22.2B$16.7B, below the path
- FY2030$27.2B$19.2B, below the path
Each year's revenue at 22% growth from $11.6B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Instruments & Supplies · listed on NASDAQ
- Revenue, FY2025
- $10.1B
- Growth, 3 years a year
- 19%
- Cash margin
- 25%
- Net cash
- $5.9B
- Shares, 3-year change
- +0.2%
- Dividend yield
- 0%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.